BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mielcarek M, Zielonka D, Carnemolla A, Marcinkowski JT, Guidez F. HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements. Front Cell Neurosci. 2015;9:42. [PMID: 25759639 DOI: 10.3389/fncel.2015.00042] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 7.1] [Reference Citation Analysis]
Number Citing Articles
1 Gong M, Yu Y, Liang L, Vuralli D, Froehler S, Kuehnen P, Du Bois P, Zhang J, Cao A, Liu Y, Hussain K, Fielitz J, Jia S, Chen W, Raile K. HDAC4 mutations cause diabetes and induce β-cell FoxO1 nuclear exclusion. Mol Genet Genomic Med 2019;7:e602. [PMID: 30968599 DOI: 10.1002/mgg3.602] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Buonvicino D, Felici R, Ranieri G, Caramelli R, Lapucci A, Cavone L, Muzzi M, Di Pietro L, Bernardini C, Zwergel C, Valente S, Mai A, Chiarugi A. Effects of Class II-Selective Histone Deacetylase Inhibitor on Neuromuscular Function and Disease Progression in SOD1-ALS Mice. Neuroscience 2018;379:228-38. [PMID: 29588251 DOI: 10.1016/j.neuroscience.2018.03.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
3 Davis KC, Saito K, Rodeghiero SR, Toth BA, Lutter M, Cui H. Behavioral Alterations in Mice Carrying Homozygous HDAC4 A778T Missense Mutation Associated With Eating Disorder. Front Neurosci 2020;14:139. [PMID: 32153359 DOI: 10.3389/fnins.2020.00139] [Reference Citation Analysis]
4 Gan L, England E, Yang JY, Toulme N, Ambati S, Hartzell DL, Meagher RB, Baile CA. A 72-hour high fat diet increases transcript levels of the neuropeptide galanin in the dorsal hippocampus of the rat. BMC Neurosci 2015;16:51. [PMID: 26260473 DOI: 10.1186/s12868-015-0188-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
5 Zeng LS, Yang XZ, Wen YF, Mail SJ, Wang MH, Zhang MY, Zheng XF, Wang HY. Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma. Aging (Albany NY). 2016;8:1236-1249. [PMID: 27295551 DOI: 10.18632/aging.100980] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
6 Moos WH, Maneta E, Pinkert CA, Irwin MH, Hoffman ME, Faller DV, Steliou K. Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia. Drug Dev Res 2016;77:53-72. [PMID: 26899191 DOI: 10.1002/ddr.21295] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
7 Park S, Bello A, Arai Y, Ahn J, Kim D, Cha KY, Baek I, Park H, Lee SH. Functional Duality of Chondrocyte Hypertrophy and Biomedical Application Trends in Osteoarthritis. Pharmaceutics 2021;13:1139. [PMID: 34452101 DOI: 10.3390/pharmaceutics13081139] [Reference Citation Analysis]
8 Main P, Tan WJ, Wheeler D, Fitzsimons HL. Increased Abundance of Nuclear HDAC4 Impairs Neuronal Development and Long-Term Memory. Front Mol Neurosci 2021;14:616642. [PMID: 33859551 DOI: 10.3389/fnmol.2021.616642] [Reference Citation Analysis]
9 Hou F, Li D, Yu H, Kong Q. The mechanism and potential targets of class II HDACs in angiogenesis. J Cell Biochem 2018;119:2999-3006. [PMID: 29091298 DOI: 10.1002/jcb.26476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Luckhurst CA, Breccia P, Stott AJ, Aziz O, Birch HL, Bürli RW, Hughes SJ, Jarvis RE, Lamers M, Leonard PM, Matthews KL, McAllister G, Pollack S, Saville-Stones E, Wishart G, Yates D, Dominguez C. Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class IIa Histone Deacetylase (HDAC) Inhibitors. ACS Med Chem Lett 2016;7:34-9. [PMID: 26819662 DOI: 10.1021/acsmedchemlett.5b00302] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
11 Mayo JC, Sainz RM, González Menéndez P, Cepas V, Tan DX, Reiter RJ. Melatonin and sirtuins: A "not-so unexpected" relationship. J Pineal Res 2017;62. [PMID: 28109165 DOI: 10.1111/jpi.12391] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 16.6] [Reference Citation Analysis]
12 Guo Z, Zhang Z, Wang Q, Zhang J, Wang L, Zhang Q, Li H, Wu S. Manganese chloride induces histone acetylation changes in neuronal cells: Its role in manganese-induced damage. Neurotoxicology 2018;65:255-63. [PMID: 29155171 DOI: 10.1016/j.neuro.2017.11.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
13 Chandran JS, Sharp PS, Karyka E, Aves-Cruzeiro JMDC, Coldicott I, Castelli L, Hautbergue G, Collins MO, Azzouz M. Site Specific Modification of Adeno-Associated Virus Enables Both Fluorescent Imaging of Viral Particles and Characterization of the Capsid Interactome. Sci Rep 2017;7:14766. [PMID: 29116194 DOI: 10.1038/s41598-017-15255-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
14 Meyners C, Wolff B, Kleinschek A, Krämer A, Meyer-almes F. Perfluorinated hydroxamic acids are potent and selective inhibitors of HDAC-like enzymes from Pseudomonas aeruginosa. Bioorganic & Medicinal Chemistry Letters 2017;27:1508-12. [DOI: 10.1016/j.bmcl.2017.02.050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Mielcarek M. Huntington's disease is a multi-system disorder. Rare Dis 2015;3:e1058464. [PMID: 26459693 DOI: 10.1080/21675511.2015.1058464] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
16 Santos-barriopedro I, Raurell-vila H, Vaquero A. The Role of HATs and HDACs in Cell Physiology and Disease. In: Mandal SS, editor. Gene Regulation, Epigenetics and Hormone Signaling. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2017. pp. 101-36. [DOI: 10.1002/9783527697274.ch4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
17 Wu Q, Yang X, Zhang L, Zhang Y, Feng L. Nuclear Accumulation of Histone Deacetylase 4 (HDAC4) Exerts Neurotoxicity in Models of Parkinson’s Disease. Mol Neurobiol 2017;54:6970-83. [DOI: 10.1007/s12035-016-0199-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
18 Sharma S, Taliyan R. Transcriptional dysregulation in Huntington's disease: The role of histone deacetylases. Pharmacol Res 2015;100:157-69. [PMID: 26254871 DOI: 10.1016/j.phrs.2015.08.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
19 Kameshima S, Okada M, Yamawaki H. Expression and localization of calmodulin-related proteins in brain, heart and kidney from spontaneously hypertensive rats. Biochem Biophys Res Commun 2016;469:654-8. [PMID: 26697749 DOI: 10.1016/j.bbrc.2015.12.048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
20 Saha P, Gupta R, Sen T, Sen N. Histone Deacetylase 4 Downregulation Elicits Post-Traumatic Psychiatric Disorders through Impairment of Neurogenesis. J Neurotrauma 2019;36:3284-96. [PMID: 31169064 DOI: 10.1089/neu.2019.6373] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
21 Schizas D, Mastoraki A, Naar L, Tsilimigras DI, Katsaros I, Fragkiadaki V, Karachaliou GS, Arkadopoulos N, Liakakos T, Moris D. Histone Deacetylases (HDACs) in Gastric Cancer: An Update of their Emerging Prognostic and Therapeutic Role. Curr Med Chem 2020;27:6099-111. [PMID: 31309879 DOI: 10.2174/0929867326666190712160842] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
22 Fitzsimons HL. The Class IIa histone deacetylase HDAC4 and neuronal function: Nuclear nuisance and cytoplasmic stalwart? Neurobiology of Learning and Memory 2015;123:149-58. [DOI: 10.1016/j.nlm.2015.06.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
23 Chang L, Kan L. Mesenchymal Stem Cell-Originated Exosomal Circular RNA circFBXW7 Attenuates Cell Proliferation, Migration and Inflammation of Fibroblast-Like Synoviocytes by Targeting miR-216a-3p/HDAC4 in Rheumatoid Arthritis. J Inflamm Res 2021;14:6157-71. [PMID: 34853524 DOI: 10.2147/JIR.S336099] [Reference Citation Analysis]
24 Zhang H, Liu T, Zhang Z, Payne SH, Zhang B, McDermott JE, Zhou JY, Petyuk VA, Chen L, Ray D, Sun S, Yang F, Chen L, Wang J, Shah P, Cha SW, Aiyetan P, Woo S, Tian Y, Gritsenko MA, Clauss TR, Choi C, Monroe ME, Thomas S, Nie S, Wu C, Moore RJ, Yu KH, Tabb DL, Fenyö D, Bafna V, Wang Y, Rodriguez H, Boja ES, Hiltke T, Rivers RC, Sokoll L, Zhu H, Shih IM, Cope L, Pandey A, Zhang B, Snyder MP, Levine DA, Smith RD, Chan DW, Rodland KD; CPTAC Investigators. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell 2016;166:755-65. [PMID: 27372738 DOI: 10.1016/j.cell.2016.05.069] [Cited by in Crossref: 493] [Cited by in F6Publishing: 429] [Article Influence: 82.2] [Reference Citation Analysis]
25 Polis B, Srikanth KD, Gurevich V, Bloch N, Gil-Henn H, Samson AO. Arginase Inhibition Supports Survival and Differentiation of Neuronal Precursors in Adult Alzheimer's Disease Mice. Int J Mol Sci 2020;21:E1133. [PMID: 32046281 DOI: 10.3390/ijms21031133] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
26 Chen YA, Lu CH, Ke CC, Chiu SJ, Chang CW, Yang BH, Gelovani JG, Liu RS. Evaluation of Class IIa Histone Deacetylases Expression and In Vivo Epigenetic Imaging in a Transgenic Mouse Model of Alzheimer's Disease. Int J Mol Sci 2021;22:8633. [PMID: 34445342 DOI: 10.3390/ijms22168633] [Reference Citation Analysis]
27 Boros F, Vécsei L. Progress in the development of kynurenine and quinoline-3-carboxamide-derived drugs. Expert Opinion on Investigational Drugs 2020;29:1223-47. [DOI: 10.1080/13543784.2020.1813716] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Ren J, Panther E, Liao X, Grammer AC, Lipsky PE, Reilly CM. The Impact of Protein Acetylation/Deacetylation on Systemic Lupus Erythematosus. Int J Mol Sci 2018;19:E4007. [PMID: 30545086 DOI: 10.3390/ijms19124007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
29 Krishna K, Behnisch T, Sajikumar S. Inhibition of Histone Deacetylase 3 Restores Amyloid-β Oligomer-Induced Plasticity Deficit in Hippocampal CA1 Pyramidal Neurons. J Alzheimers Dis 2016;51:783-91. [PMID: 26890755 DOI: 10.3233/JAD-150838] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
30 Chen Z, Zhang Z, Guo L, Wei X, Zhang Y, Wang X, Wei L. The role of histone deacetylase 4 during chondrocyte hypertrophy and endochondral bone development. Bone Joint Res 2020;9:82-9. [PMID: 32435460 DOI: 10.1302/2046-3758.92.BJR-2019-0172.R1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
31 V Stoddard S, Dodson K, Adams K, L Watkins D. In silico Design of Novel Histone Deacetylase 4 Inhibitors: Design Guidelines for Improved Binding Affinity. Int J Mol Sci 2019;21:E219. [PMID: 31905609 DOI: 10.3390/ijms21010219] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
32 Meyners C, Mertens M, Wessig P, Meyer-almes F. A Fluorescence-Lifetime-Based Binding Assay for Class IIa Histone Deacetylases. Chem Eur J 2017;23:3107-16. [DOI: 10.1002/chem.201605140] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
33 Luckhurst CA, Aziz O, Beaumont V, Bürli RW, Breccia P, Maillard MC, Haughan AF, Lamers M, Leonard P, Matthews KL, Raphy G, Stott AJ, Munoz-sanjuan I, Thomas B, Wall M, Wishart G, Yates D, Dominguez C. Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor. Bioorganic & Medicinal Chemistry Letters 2019;29:83-8. [DOI: 10.1016/j.bmcl.2018.11.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
34 Sild M, Booij L. Histone deacetylase 4 (HDAC4): a new player in anorexia nervosa? Mol Psychiatry 2019;24:1425-34. [PMID: 30742020 DOI: 10.1038/s41380-019-0366-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
35 Chang CH, Kuek EJW, Su CL, Gean PW. MicroRNA-206 Regulates Stress-Provoked Aggressive Behaviors in Post-weaning Social Isolation Mice. Mol Ther Nucleic Acids 2020;20:812-22. [PMID: 32464545 DOI: 10.1016/j.omtn.2020.05.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
36 Schweipert M, Jänsch N, Upadhyay N, Tilekar K, Wozny E, Basheer S, Wurster E, Müller M, C S R, Meyer-Almes FJ. Mechanistic Insights into Binding of Ligands with Thiazolidinedione Warhead to Human Histone Deacetylase 4. Pharmaceuticals (Basel) 2021;14:1032. [PMID: 34681256 DOI: 10.3390/ph14101032] [Reference Citation Analysis]
37 Fallah MS, Szarics D, Robson CM, Eubanks JH. Impaired Regulation of Histone Methylation and Acetylation Underlies Specific Neurodevelopmental Disorders. Front Genet 2020;11:613098. [PMID: 33488679 DOI: 10.3389/fgene.2020.613098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Schizas D, Mastoraki A, Naar L, Spartalis E, Tsilimigras DI, Karachaliou GS, Bagias G, Moris D. Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment. World J Gastroenterol 2018; 24(41): 4635-4642 [PMID: 30416311 DOI: 10.3748/wjg.v24.i41.4635] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
39 Yuan H, Denton K, Liu L, Li XJ, Benashski S, McCullough L, Li J. Nuclear translocation of histone deacetylase 4 induces neuronal death in stroke. Neurobiol Dis 2016;91:182-93. [PMID: 26969532 DOI: 10.1016/j.nbd.2016.03.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
40 Critchley BJ, Isalan M, Mielcarek M. Neuro-Cardio Mechanisms in Huntington's Disease and Other Neurodegenerative Disorders. Front Physiol 2018;9:559. [PMID: 29875678 DOI: 10.3389/fphys.2018.00559] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
41 Ricci A, Galluzzi L, Magnani M, Menotta M. DDIT4 gene expression is switched on by a new HDAC4 function in ataxia telangiectasia. FASEB J 2020;34:1802-18. [PMID: 31914654 DOI: 10.1096/fj.201902039R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Bjørklund G, Chirumbolo S, Geier DA, Kern JK, Geier MR. Histone deacetylase inhibitors, Thimerosal, and autism spectrum disorder. Environ Res 2017;156:843-4. [PMID: 28410622 DOI: 10.1016/j.envres.2017.04.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
43 D'Mello SR. When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease. Int J Mol Sci 2021;22:5911. [PMID: 34072862 DOI: 10.3390/ijms22115911] [Reference Citation Analysis]
44 Mielcarek M, Isalan M. A shared mechanism of muscle wasting in cancer and Huntington's disease. Clin Transl Med 2015;4:34. [PMID: 26668061 DOI: 10.1186/s40169-015-0076-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
45 Onaolapo OJ, Onaolapo AY, Olowe OA, Udoh MO, Udoh DO, Nathaniel TI. Melatonin and Melatonergic Influence on Neuronal Transcription Factors: Implications for the Development of Novel Therapies for Neurodegenerative Disorders. Curr Neuropharmacol 2020;18:563-77. [PMID: 31885352 DOI: 10.2174/1570159X18666191230114339] [Reference Citation Analysis]
46 Rai SN, Singh BK, Rathore AS, Zahra W, Keswani C, Birla H, Singh SS, Dilnashin H, Singh SP. Quality Control in Huntington's Disease: a Therapeutic Target. Neurotox Res 2019;36:612-26. [PMID: 31297710 DOI: 10.1007/s12640-019-00087-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
47 Banik D, Moufarrij S, Villagra A. Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy. Int J Mol Sci 2019;20:E2241. [PMID: 31067680 DOI: 10.3390/ijms20092241] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 15.7] [Reference Citation Analysis]
48 Piotrowska I, Isalan M, Mielcarek M. Early transcriptional alteration of histone deacetylases in a murine model of doxorubicin-induced cardiomyopathy. PLoS One 2017;12:e0180571. [PMID: 28662206 DOI: 10.1371/journal.pone.0180571] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
49 Li MH, Chang HC, Feng CF, Yu HW, Shiue CY. Synthesis and Evaluation of 18F-INER-1577-3 as a Central Nervous System (CNS) Histone Deacetylase Imaging Agent. Curr Med Imaging 2020;16:978-90. [PMID: 33081659 DOI: 10.2174/1573405615666191008160809] [Reference Citation Analysis]
50 González-Hedström D, Priego T, López-Calderón A, Amor S, de la Fuente-Fernández M, Inarejos-García AM, García-Villalón ÁL, Martín AI, Granado M. Beneficial Effects of a Mixture of Algae and Extra Virgin Olive Oils on the Age-Induced Alterations of Rodent Skeletal Muscle: Role of HDAC-4. Nutrients 2020;13:E44. [PMID: 33375628 DOI: 10.3390/nu13010044] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]